Marcel Fontecha

Title: Innovations by Marcel Fontecha

Introduction

Marcel Fontecha is an accomplished inventor based in San Ramon, CA (US). He holds three patents that showcase his contributions to the fields of molecular diagnostics and infectious disease detection. His work has significant implications for public health and disease management.

Latest Patents

Marcel Fontecha's latest patents include compositions and methods for detecting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A, and Influenza B. These patents describe methods for the rapid detection of the presence or absence of these viruses in biological or non-biological samples. The methods involve performing an amplifying step, a hybridizing step, and a detecting step. Additionally, the patents provide primers and probes targeting SARS-CoV-2, Influenza A, and Influenza B, along with kits designed for their detection. Another notable patent focuses on methods and compositions for classifying Diffuse Large B-Cell Lymphoma (DLBCL) subtypes using quantitative RT-PCR.

Career Highlights

Marcel has worked with prominent companies in the biotechnology sector, including Roche Molecular Systems, Inc. and Roche Diagnostics GmbH. His experience in these organizations has allowed him to develop innovative solutions that address critical health challenges.

Collaborations

Marcel has collaborated with notable professionals in his field, including Christopher David Santini and Rajiv Dua. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Marcel Fontecha's innovative work in the detection of infectious diseases and classification of lymphoma subtypes highlights his significant contributions to medical science. His patents reflect a commitment to improving diagnostic methods and enhancing public health outcomes.